CLD18 - Overview: Claudin 18 (CLDN18) (43-14A), Semi-Quantitative Immunohistochemistry, Manual

Identification of tumor cells expressing claudin 18 As an aid in screening patients who may be eligible for VYLOY (zolbetuximab) treatment

CARTA - Overview: Carbamazepine, Total, Serum

Monitoring therapy Determining compliance Assessing toxicity

CK - Overview: Creatine Kinase (CK), Serum

Diagnosing and monitoring myopathies or other trauma, toxin, or drug-induced muscle injury

CALX - Overview: CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN), Reflex, Varies

Aiding in the distinction between a reactive cytosis and a chronic myeloproliferative disorder Evaluating mutations in CALR in an algorithmic process for the MPNR / Myeloproliferative Neoplasm, JAK2 V617F with Reflex to CALR and MPL,...

CLOBZ - Overview: Clobazam and Metabolite, Serum

Monitoring clobazam therapy

CDOU - Overview: Cadmium Occupational Exposure, Random, Urine

Detecting occupational exposure to cadmium using random urine specimens

EXHR - Overview: Hematologic Disorders, DNA and RNA Extract and Hold, Varies

Reserving nucleic acids on any specimen for which molecular analysis requiring DNA or RNA may be necessary at a future date, ensuring that adequate material for testing is available

FVAG - Overview: Fungal Culture, Vaginal

Monitoring therapy for vulvovaginitis Managing chronic recurring disease Determining the etiology of infectious vaginitis when other tests have been uninformative

FLUOX - Overview: Fluoxetine, Serum

Monitoring serum concentration of fluoxetine during therapy Evaluating potential toxicity Evaluating patient compliance

TULI - Overview: Francisella tularensis Antibody, IgM and IgG, Technical Interpretation, Serum

Interpretation to aid in the diagnosis of tularemia caused by Francisella tularensis